Morula Health’s case studies demonstrate how our specialist clinical, regulatory, and safety medical writing teams support biotech and life science companies through complex development and submission challenges.
Each example highlights our ability to apply therapy‑area expertise, regulatory insight, and document‑level precision to real‑world programs, helping clients progress INDs, CTAs, and marketing applications with confidence. Together, these case studies show how expert medical writing contributes directly to regulatory success, operational efficiency, and informed decision‑making.
Helping a US Rare Disease Biotech Navigate an Unfamiliar Regulatory Landscape: MHRA Scientific Advice Briefing Package Development
When a US biotech sought MHRA Scientific Advice to support its UK development strategy, it needed to adapt existing regulatory content to an unfamiliar framework…
Find out more
Investigator’s Brochure Update for an Inflammation Program: Coordinating Stakeholders, Timelines, and Reviews
When a leading US biotechnology company needed to update the Investigator's Brochure (IB) for its Phase 1 atopic dermatitis therapy, Morula Health provided dedicated scientific…
Find out more
FDA-aligned CSR and Narrative Writing Support for Complex Immuno-Oncology Programs
UK biotech transitioning from a freelance medical writer to a scalable partner, delivering FDA‑aligned immuno‑oncology CSRs and safety narratives to support US expansion. As program…
Find out more
Globalizing a China-Developed Asset: Rapid IB Update for FDA (US) and TGA (Australia) Submission
Morula Health was engaged to review and refine a translated IB to ensure alignment with Australian (TGA) and US (FDA) regulatory expectations and was suitable…
Find out more
Helping a Biotech Secure FDA Breakthrough Therapy Designation
Morula Health supported a European biotech with specialist regulatory medical writing for an FDA Breakthrough Therapy Designation submission. By delivering a clear, evidence‑driven dossier aligned…
Find out more
Strengthening IND Preparation Through Expert Nonclinical CTD Support
A UK biotech preparing for IND submission partnered with Morula Health for nonclinical medical writing support. Our writers delivered CTD‑ready documentation aligned to regulatory guidance,…
Find out more
Accelerating Global AMR Research Program
Morula Health provided embedded medical writing support across a complex global antimicrobial resistance (AMR) program. By ensuring consistency across documents and applying deep infectious‑disease expertise,…
Find out more
How Morula Health saved a US biotech time and resources on a complex Phase 2 CSR
Morula Health supported a US biotech with the delivery of a complex Phase 2 Clinical Study Report. Our specialist clinical writers applied therapeutic and document‑level…
Find out more
Breaking Barriers: Facilitating FDA Approval
Morula Health developed a first‑in‑human Phase 1 protocol for an FDA IND submission within five weeks. By combining regulatory insight with immuno‑oncology expertise, our team…
Find out more